We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+10.17%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$15.4B
AUM Growth
+$2.08B
Cap. Flow
+$1.36B
Cap. Flow %
8.86%
Top 10 Hldgs %
54.82%
Holding
115
New
20
Increased
35
Reduced
31
Closed
11

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$702M
2
CELG
Celgene Corp
CELG
+$666M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$459M
4
RHT
Red Hat Inc
RHT
+$333M
5
AGN
Allergan plc
AGN
+$138M

Top Sells

Rank Stock Value
1
TRU icon
TransUnion
TRU
+$181M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$173M
3
META icon
Meta Platforms (Facebook)
META
+$169M
4
BKNG icon
Booking.com
BKNG
+$157M
5
GG
Goldcorp Inc
GG
+$148M

Sector Composition

Rank Sector Weight
1 Healthcare 33.27%
2 Technology 17.66%
3 Communication Services 13.38%
4 Industrials 6.69%
5 Consumer Discretionary 4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.45T
$168M 1.1%
1,257,503
-372,898
-23% -$47.3M
AGN
27
DELISTED
Allergan plc
AGN
$167M 1.09%
+1,000,000
New +$138M
CI icon
28
Cigna
CI
$73.7B
$165M 1.08%
1,050,000
+105,000
+11% +$16.5M
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.36T
$154M 1%
2,844,460
-3,002,100
-51% -$173M
IOVA icon
30
Iovance Biotherapeutics
IOVA
$1.82B
$140M 0.91%
5,725,000
– –
TRU icon
31
TransUnion
TRU
$15.1B
$123M 0.8%
1,672,343
-2,645,503
-61% -$181M
SE icon
32
Sea Limited
SE
$65.4B
$112M 0.73%
3,375,000
-3,545,000
-51% -$96.1M
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$102M 0.67%
995,000
-205,000
-17% -$16M
MYOK
34
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$100M 0.65%
2,000,000
+49,722
+3% +$2.42M
XLRN
35
DELISTED
Acceleron Pharma
XLRN
$97.6M 0.63%
2,375,000
– –
LBTYK icon
36
Liberty Global Class C
LBTYK
$3.53B
$97.5M 0.63%
3,675,974
-632,132
-15% -$16.2M
ZGNX
37
DELISTED
Zogenix, Inc.
ZGNX
$95.6M 0.62%
2,000,000
-50,500
-2% -$2.03M
ZAYO
38
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$92.8M 0.6%
+2,820,000
New +$90M
SAGE
39
DELISTED
Sage Therapeutics
SAGE
$91.5M 0.6%
500,000
-100,000
-17% -$17.1M
BABA icon
40
Alibaba
BABA
$293B
$84.7M 0.55%
500,000
+85,000
+20% +$14.7M
AMRN
41
Amarin Corp
AMRN
$299M
$82.4M 0.54%
212,500
+50,000
+31% +$18.3M
ENTA icon
42
Enanta Pharmaceuticals
ENTA
$366M
$81M 0.53%
960,000
+20,000
+2% +$1.8M
ALNY icon
43
Alnylam Pharmaceuticals
ALNY
$27.5B
$79.8M 0.52%
1,100,000
+600,000
+120% +$46M
ONCE
44
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$78.8M 0.51%
770,000
-50,000
-6% -$5.4M
GWR
45
DELISTED
Genesee & Wyoming Inc.
GWR
$77.5M 0.5%
+775,000
New +$70.7M
KYNB
46
Kyntra Bio
KYNB
$27.2M
$76.8M 0.5%
68,000
+31,377
+86% +$34.3M
SRPT icon
47
Sarepta Therapeutics
SRPT
$1.57B
$76M 0.49%
500,000
-150,000
-23% -$18.2M
NVCR icon
48
NovoCure
NVCR
$1.73B
$75.9M 0.49%
1,200,000
+150,000
+14% +$7.6M
RETA
49
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$75.5M 0.49%
800,000
+50,000
+7% +$4.32M
S
50
DELISTED
Sprint Corporation
S
$70.1M 0.46%
10,675,000
+9,085,000
+571% +$57.4M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Farallon Capital Management held 115 positions worth $15.4B, up 16% from $13.3B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Farallon Capital Management deployed $1.36B of net new capital in Q2 2019, opening 20 new positions and adding to 35 existing holdings. Its largest new stake was Anadarko Petroleum: 10,465,000 shares worth $738M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was TransUnion, an estimated $181M trimmed.

  • Farallon Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 10,465,000 shares worth $738M.
  • Farallon Capital Management added most to Celgene Corp in Q2 2019, an estimated $666M increase.
  • Farallon Capital Management's biggest Q2 2019 reduction was TransUnion, cutting an estimated $181M.
  • Farallon Capital Management fully exited Goldcorp Inc in Q2 2019, selling an estimated $148M.
  • Farallon Capital Management's ten largest holdings make up 55% of its $15.4B portfolio in Q2 2019.
  • Farallon Capital Management opened 20 new positions and closed 11 in Q2 2019.
  • Farallon Capital Management's portfolio value rose 16% quarter-over-quarter to $15.4B.

Based on Farallon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.